Kamila Pytel

Kamila Pytel is a seasoned professional in analytical development within the biopharmaceutical sector, currently serving as Associate Director of CMC Analytical Development at Novartis UK since September 2022. Pytel previously held a similar role at Gyroscope Therapeutics, where responsibilities included the establishment of an analytical laboratory and management of a multi-functional team focused on AAV gene therapy products. Prior to that, experience at Pfizer involved developing analytical assays for AAV targets, and a research associate position at Imperial College London contributed to significant advancements in gene therapy research. Pytel's early career included research roles at Horizon Discovery and Prionics AG, where innovative methodologies for viral detection were developed. Educated with a PhD in Bio-medical Sciences from Aston University and a Master's degree in Molecular Biology from Jagiellonian University, Pytel combines robust scientific expertise with leadership in complex R&D environments.